ClinicalTrials.Veeva

Menu

Optoacoustic Images Versus Imagio® Ultrasound (Reader-02)

S

Seno Medical

Status

Completed

Conditions

Breast Cancer

Treatments

Device: Mammography
Device: Reader Study Imagio Ultrasound + Optoacoustic Imaging
Device: Reader Study - Imagio Ultrasound

Study type

Interventional

Funder types

Industry

Identifiers

NCT04030104
Reader-02 Study

Details and patient eligibility

About

The Imagio® Pivotal Study is intended to evaluate if the results observed in the previous Feasibility Study can be confirmed for pre-specified effectiveness endpoints. Using Intention-to-Diagnose (ITD) masses from the PIONEER Pivotal study, 480 to 840 masses are to be used for the Pivotal Study, the remaining masses will be reserved for training the SenoGram® model.

Full description

This will be a controlled, blinded, multi-reader, multi-case (MRMC) study using a sequential design. The study will include 15 readers with an additional 5 as back-up readers depending on qualifications and availability. Readers that participated in the Seno PIONEER Study (NCT01943916) or the Reader-01 Feasibility Study (NCT03708393) are not eligible to participate as readers in this Pivotal Study.

Imagio® [Ultrasound (IUS) + Optoacoustic (OA)] (IUS)(IUS+OA) training will be completed prior to any reads taking place. Read 1 will be immediately followed by Read 2 within the same read session.

Enrollment

480 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • One analyzable mass per patient: BI-RADS 3 and 4a, 4b, 4c and 5 masses as declared by clinical site investigator via PIONEER study inclusion criteria and categorized as BIRADS 3, 4a, 4b 4c and 5 by conventional diagnostic ultrasound (CDU)
  • Masses declared to be in the PIONEER Intention to Diagnose (ITD)/analysis population, including high risk cases per original PIONEER protocol
  • Patient age, indication for study entry and available medical history
  • Evaluable mammograms and OA and IUS video loops and stills for each mass

Exclusion criteria

  • Critical missing IUS or OA still image and/or video loop views or incorrect IUS or OA stills and video loops that would preclude a case from being evaluated by readers
  • Reader-02 Proficiency Test and training cases

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

Single Blind

480 participants in 2 patient groups

Imagio IUS
Active Comparator group
Description:
Read 1 (Control): History + Mammogram (if available) + IUS (Imagio Ultrasound) stills and videos provided), IUS Probability of Malignancy (POM) and Breast Imaging Reporting and Data System (BI-RADS) scored and the data form then locked.
Treatment:
Device: Reader Study - Imagio Ultrasound
Device: Mammography
Imagio (IUS+OA)
Experimental group
Description:
Read 2 (Test): History + Mammogram (if available) + IUS (stills and videos provided), and Imagio (IUS+OA) (stills and videos provided). Imagio (IUS+OA) POM and Breast Imaging Reporting and Data System (BI-RADS) assigned after viewing the SenoGram® output. The dataform is locked.
Treatment:
Device: Reader Study Imagio Ultrasound + Optoacoustic Imaging
Device: Mammography

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems